Richard J. Rodgers
VP & Controller, MGI PHARMA INC.
Companies
- NovavaxBoard member Nov 1, 2022 to now1
- Opus Genetics, Inc.Board member Dec 3, 2014 to now2
- Ardelyx (United States)Board member Jun 18, 2014 to now3
- Sagimet Biosciences Inc.Board member Jul 13, 2023 to Jul 20, 20234
- Opus Genetics, Inc.Chief executive officer Apr 21, 2023 to Apr 21, 20235
- Opus Genetics, Inc.President Apr 21, 2023 to Apr 21, 20235
- TesaroChief financial officer Jun 27, 2012 to Mar 8, 20136
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ardelyx (United States) ARDX439,998 shares7$1.4M at $3.10Jun 16, 2026
- Opus Genetics, Inc. IRD343,022 shares8$1.3M at $3.79Apr 20, 2026
Novavax NVAX47,370 shares9$512.5K at $10.82Jun 20, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 20, 2026Exercised options 18,880 shares of Novavax9
- Jun 16, 2026Granted 26,455 shares of Ardelyx (United States)7
- Apr 20, 2026Granted 24,367 shares of Opus Genetics, Inc.8
- Oct 29, 2025Exercised options 3,800 shares of Novavax10
- Jun 18, 2025Granted 41,551 shares of Ardelyx (United States)11
- Jun 18, 2025Granted 21,468 shares of Ardelyx (United States)11
- Jun 12, 2025Exercised options 10,420 shares of Novavax12
- Apr 30, 2025Granted 79,504 shares of Opus Genetics, Inc.13
- Jan 16, 2025Exercised options 100,000 shares at $0.55 of Ardelyx (United States)14
- Oct 29, 2024Exercised options 3,800 shares of Novavax15
- Jun 14, 2024Granted 12,204 shares of Ardelyx (United States)16
- Jun 12, 2024Exercised options 6,670 shares of Novavax17
- Jun 11, 2024Granted 41,143 shares of Opus Genetics, Inc.18
- Jan 1, 2024Granted 24,762 shares of Opus Genetics, Inc.19
- Nov 1, 2023Granted 35,000 shares of Opus Genetics, Inc.20
- Oct 29, 2023Exercised options 3,800 shares of Novavax21
- Jun 15, 2023Granted 18,494 shares of Ardelyx (United States)22
- Apr 19, 2023Granted 50,000 shares of Opus Genetics, Inc.23
- Jan 11, 2023Granted 20,822 shares of Opus Genetics, Inc.24
- Oct 3, 2022Exercised 3,148 shares of Opus Genetics, Inc.25
- Jul 1, 2022Granted 15,841 shares of Opus Genetics, Inc.26
- Jul 1, 2022Granted 7,812 shares of Opus Genetics, Inc.26
- Jun 15, 2022Granted 132,299 shares of Ardelyx (United States)27
- Apr 1, 2022Granted 4,629 shares of Opus Genetics, Inc.28
- Jan 3, 2022Granted 4,021 shares of Opus Genetics, Inc.29
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNovavax, Board member
- 2SEC EDGAROpus Genetics, Inc., Board member
- 3
- 4
- 5
- 6SEC EDGARTesaro, Chief financial officer
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Oct 30, 2025
- 11SEC EDGARForm 4 filed Jun 23, 2025
- 12SEC EDGARForm 4 filed Jun 13, 2025
- 13SEC EDGARForm 4 filed May 2, 2025
- 14SEC EDGARForm 4 filed Jan 17, 2025
- 15SEC EDGARForm 4 filed Jan 2, 2025
- 16SEC EDGARForm 4 filed Jun 17, 2024
- 17SEC EDGARForm 4 filed Jun 14, 2024
- 18SEC EDGARForm 4 filed Jun 13, 2024
- 19SEC EDGARForm 4 filed Jan 3, 2024
- 20SEC EDGARForm 4 filed Nov 13, 2023
- 21SEC EDGARForm 4 filed Oct 31, 2023
- 22SEC EDGARForm 4 filed Jun 16, 2023
- 23SEC EDGARForm 4 filed Apr 21, 2023
- 24SEC EDGARForm 4 filed Jan 12, 2023
- 25SEC EDGARForm 4 filed Oct 4, 2022
- 26SEC EDGARForm 4 filed Jul 6, 2022
- 27SEC EDGARForm 4 filed Jun 17, 2022
- 28SEC EDGARForm 4 filed Apr 5, 2022
- 29SEC EDGARForm 4 filed Jan 5, 2022